Thieme E-Books & E-Journals -
Back
Pharmacopsychiatry 2007; 40(3): 111-115
DOI: 10.1055/s-2007-977714
Original Paper

© Georg Thieme Verlag KG · Stuttgart · New York

The Association between Exposure to COX-2 Inhibitors and Schizophrenia Deterioration. A Nested Case-Control Study

P. Stolk 1 , P. C. Souverein 1 , H. G. M. Leufkens 1 , J. G. Weil 2 , A. C. G. Egberts 1 , E. R. Heerdink 1
  • 1Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Utrecht, The Netherlands
  • 2GlaxoSmithkline, Worldwide Epidemiology (Neurosciences), United Kingdom